SOLARA

Solara Active Pharma Sciences Share Price

₹675.30 -7.55 (-1.11%)

28 Dec, 2024 02:57

SIP TrendupStart SIP in SOLARA

Start SIP

Performance

  • Low
  • ₹672
  • High
  • ₹693
  • 52 Week Low
  • ₹323
  • 52 Week High
  • ₹883
  • Open Price₹687
  • Previous Close₹683
  • Volume61,455

Investment Returns

  • Over 1 Month -17.9%
  • Over 3 Month -15.77%
  • Over 6 Month + 40.29%
  • Over 1 Year + 94.93%
SIP Lightning

Smart Investing Starts Here Start SIP with Solara Active Pharma Sciences for Steady Growth!

Invest Now

Solara Active Pharma Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -5.1
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 2,718
  • P/B Ratio
  • 2.9
  • Average True Range
  • 36.29
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -21.12
  • RSI
  • 33.8
  • MFI
  • 23.17

Solara Active Pharma Sciences Financials

Solara Active Pharma Sciences Technicals

EMA & SMA

Current Price
₹675.30
-7.55 (-1.11%)
pointer
  • stock-down_img
  • Bullish Moving Average 4
  • stock-up_img
  • Bearish Moving Average 12
  • 20 Day
  • ₹727.62
  • 50 Day
  • ₹748.55
  • 100 Day
  • ₹719.27
  • 200 Day
  • ₹638.45

Resistance and Support

679.93 Pivot Speed
  • R3 709.72
  • R2 701.33
  • R1 688.32
  • S1 666.92
  • S2 658.53
  • S3 645.52

What's your outlook on Solara Active Pharma Sciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Solara Active Pharma Sciences Ltd. is a leading pharmaceutical company in India, specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on innovation, quality, and sustainability, catering to various therapeutic segments in the global market.

Solara Active Pharma Scis has an operating revenue of Rs. 1,258.60 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of -38% needs improvement, ROE of -60% is poor and needs improvement. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 12% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -19% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Solara Active Pharma Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-21 Quarterly Results
2024-07-22 Quarterly Results
2024-05-29 Audited Results
2024-05-09 To consider Fund Raising
2024-02-14 Quarterly Results

Solara Active Pharma Sciences F&O

Solara Active Pharma Sciences Shareholding Pattern

37.27%
1.28%
14.25%
0%
18.83%
28.37%

About Solara Active Pharma Sciences

  • NSE Symbol
  • SOLARA
  • BSE Symbol
  • 541540
  • Managing Director & CEO
  • Mr. Poorvank Purohit
  • ISIN
  • INE624Z01016

Similar Stocks to Solara Active Pharma Sciences

Solara Active Pharma Sciences FAQs

Solara Active Pharma Sciences share price is ₹675 As on 28 December, 2024 | 02:43

The Market Cap of Solara Active Pharma Sciences is ₹2718.3 Cr As on 28 December, 2024 | 02:43

The P/E ratio of Solara Active Pharma Sciences is -5.1 As on 28 December, 2024 | 02:43

The PB ratio of Solara Active Pharma Sciences is 2.9 As on 28 December, 2024 | 02:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23